A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study

Gillies Mark C.; Lim Lyndell L.; Campain Anna; Quin Godfrey J.; Salem Wedad; Li Ji; Goodwin Stephanie; Aroney Christine; McAllister Ian L.; Fraser-Bell Samantha

首页> 外文期刊>Ophthalmology >A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study

【24h】

A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study

机译：玻璃体腔注射贝伐单抗与玻璃体腔注射地塞米松治疗糖尿病性黄斑水肿的随机临床试验BEVORDEX研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To report the 12-month results of the first head-to-head comparison of a dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, CA) versus bevacizumab (Avastin; Genentech, South San Francisco, CA) for center-involving diabetic macular edema (DME).

机译：目的：报告地塞米松植入物（Ozurdex; Allergan，Inc.，Irvine，CA）与贝伐单抗（Avastin; Genentech，South San Francisco，CA）首次头对头比较的12个月结果涉及糖尿病性黄斑水肿（DME）。

著录项

来源
《Ophthalmology》 |2014年第12期|共9页
作者
Gillies Mark C.; Lim Lyndell L.; Campain Anna; Quin Godfrey J.; Salem Wedad; Li Ji; Goodwin Stephanie; Aroney Christine; McAllister Ian L.; Fraser-Bell Samantha;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Progression of Diabetic Retinopathy in the Bevordex study: a randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema [J] . Lim Lyndell L., Qatarneh Dania, Hodgson Lauren, Investigative ophthalmology & visual science . 2016,第12期

机译：Bevordex研究中糖尿病视网膜病变的进展：术治疗术治疗术治疗术治疗性黄斑水肿的随机临床试验与玻术地区
2. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema [J] . Christine Aroney, Samantha Fraser-Bell, Ecosse L. Lamoureux, Investigative ophthalmology & visual science . 2016,第13期

机译：BEVORDEX研究中与视觉相关的生活质量结果：比较Ozurdex缓释地塞米松玻璃体内植入和贝伐单抗治疗糖尿病性黄斑水肿的临床试验
3. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema [J] . Aroney Christine, Fraser-Bell Samantha, Lamoureux Ecosse L., Investigative ophthalmology & visual science . 2016,第13期

机译：BEVORDEX研究中与视觉相关的生活质量结果：比较Ozurdex缓释地塞米松玻璃体内植入和贝伐单抗治疗糖尿病性黄斑水肿的临床试验
4. Pharmacokinetic Modeling to Improve the Design of Intravitreal Corticosteroid Implants for Treating Macular Edema [C] . Susan S. Lee, David Z. DArgenio, Rex A. Moats, Controlled Release Society Annual Meeting and Exposition . 2007

机译：药物动力学模型可改善玻璃体皮质类固醇植入物治疗黄斑水肿的设计
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial [O] . Farhad Fazel, Hossein Nikpour, Mohsen Pourazizi 2020

机译：玻璃体腔注射贝伐单抗和局部用多佐唑胺与单独玻璃体腔注射贝伐单抗联合治疗糖尿病性黄斑水肿：随机对侧临床试验
7. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema [O] . Christine Aroney, Samantha Fraser-Bell, Ecosse L. Lamoureux, 2016

机译：Bevordex研究中的视觉相关质量结果：临床试验，比较Ozurdex持续释放地塞米松玻璃体植入物和Bevacizumab治疗糖尿病黄斑水肿

A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema The BEVORDEX Study

摘要

著录项

相似文献

相关主题

期刊订阅